Announcements and awards
Landmark study with PerfusionPal featured in PLoS One:
Drug testing in fully humanized, 3D, perfused breast cancer model |
Lena Biosciences receives over $1.8 M Phase II SBIR grant award to apply its screening platform to toxicity testing of chemicals implicated in neurodegenerative diseases
|
2022 Finalist
Mass Challenge US Early Stage Accelerator |